Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

Inhibitors of p38MAP kinase under development at Teikoku Hormone

Aug. 25, 2000

Abbott discovers novel nonpeptidic antagonists of LFA-1/ICAM-1 interaction

Aug. 24, 2000

FDA approves Azulfidine EN-tabs as treatment of juvenile RA

Aug. 24, 2000

Selective ICAM-1 and E-selectin inhibitors on human endothelial cells explored

Aug. 22, 2000

Kyowa Hakko claims new series of NF-kappaB inhibitors

Aug. 18, 2000

Etanercept is well tolerated and efficacious as psoriatic arthritis and psoriasis treatment

Aug. 11, 2000

Patent recently issued to Abbott covering MMP inhibitors and their use

Aug. 10, 2000

Gene found to regulate protein associated with immune system disorders

Aug. 10, 2000

Phase II study of clenoliximab in rheumatoid arthritis begins

Aug. 9, 2000

Suppression of mitochondrial respiration linked to osteoarthritis

Aug. 9, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...